Metastatic rectal cancer to the breast by Li, Hsiao C et al.
[Rare Tumors 2009; 1:e22] [page 63]
Metastatic rectal cancer 
to the breast
Hsiao C. Li,
1 Prapti Patel,
1 Payal Kapur,
2
Sergio Huerta
3
University of Texas Southwestern
Medical Center/Dallas VA Medical Center
Departments of 
1Medical Oncology,
2Pathology and 
3Surgery, Dallas, TX, USA
Abstract 
Rectal cancer metastatic to the breast is an
exceedingly rare event with around 15 cases
reported in the literature. A metastatic breast
deposit from the rectum signifies diffuse dis-
seminated  disease  or  a  highly  aggressive
tumor  such  that  surgical  intervention  other
than palliation has a limited role. In the pres-
ent report, we discuss a patient who  present-
ed with rectal cancer and developed a breast
metastatic  deposit.  She  soon  developed  pro-
gressive metastatic involvement of the lungs
and  the  soft  tissues  and  succumbed  to  the
malignant course of this disease 12 months
after the diagnosis of the primary rectal tumor.
Introduction
Rectal cancer is expected to affect 40,870
Americans in 2009.
1 Up to 30% of patients with
attempted  curative  surgical  intervention  will
eventually  develop  regional  recurrence.
2
Further, nearly 70% of these patients have local
recurrence  as  well  as  distant  metastases.
3
Nineteen percent of patients newly diagnosed
with  colorectal  cancer  present  with  distant
metastasis at the time of diagnosis
4,5 and col-
orectal  cancer  patients  treated  for  cure  will
develop  metastatic  disease  of  some  form  in
nearly 40% of cases.
6 Colorectal cancers most
typically metastasize to regional lymph nodes.
The liver is the most common site of distant
metastasis followed by the lungs and bone. Up
to one quarter of liver metastases present syn-
chronously, but most commonly liver lesions
develop metachronously following treatment of
the primary colorectal tumor. Metastases from
rectal  cancer  to  multiple  organs  have  been
reported  either  as  synchronous  lesions  or
metachronous  events.
7-11 In  either  setting,
metastatic disease from the rectum to unusual
sites such as the spleen, skin or breast carries
a substantially poor prognosis. In the following
report, we present a patient with rectal cancer
metastatic  to  the  breast  whose  aggressive
tumor led to her demise within a year follow-
ing the initial diagnosis of rectal cancer.
Case Report
A 54-year old African American female pre-
sented with nausea, vomiting, and abdominal
pain.  A  computed  tomography  scan  of  the
abdomen and pelvis showed diffuse wall thick-
ening of the small bowel, colon, and rectum
with  ascites  (Figure  1A).  An  exploratory
laparotomy  revealed  a  massive  amount  of
purulent fluid and multiple loculated abscesses
as well as a rectal mass. A rigid proctoscopy
showed the mass to be 3-4 cm from the anal
verge with an obvious perforation. Drains were
placed  and  a  diverting  colostomy  was  per-
formed. Pathological evaluation of a surgical
specimen taken from the rectum showed an
invasive poorly differentiated adenocarcinoma
(Figure 2A, B, and C). A CT scan performed two
weeks after this operation showed a large het-
erogeneous soft tissue mass that distended the
rectum  to  8  cm  with  no  evidence  of  metas-
tases.  She  was  clinically  staged  as  having
cT4NxM0 adenocarcinoma of the rectum. She
remained in the hospital for two months due to
infectious  complications  then  received  pre-
operative radiation to a dose of 5040 cGy over
a period of 44 days. Concurrent chemotherapy
was recommended, but not delivered because
the patient missed multiple appointments with
medical oncology. After the completion of her
radiation  therapy,  however,  she  did  receive
three  cycles  of  capecitabine  and  oxaliplatin
with a partial response in the rectum. A total
mesorectal  excision  was  planned,  but  the
patient then developed a firm 3 cm mass in the
upper  outer  quadrant  of  the  right  breast  at
10:00 with a 2 cm firm mobile lymph node in
the right axilla. Mammographic examination
showed a 3.2 cm indistinctly marginated mass
(Figure 1B). An ultrasound of the right breast
showed a 3.7 cm hypoechoic, round mass with
ill-defined margins as well as an oval hypoe-
choic solid mass measuring 2.4 cm in the right
axilla.  An  ultrasound  guided  core  biopsy  of
both the right breast mass and the right axil-
lary lymph node showed poorly differentiated
invasive  adenocarcinoma  with  no  normal
breast parenchyma or in situbreast carcinoma.
When compared to the specimen from the pre-
vious  rectal  mass,  the  poorly  differentiated
areas  of  the  rectal  biopsy  showed  a  similar
morphology to the tumors in the breast and
right axilla. Immunostains showed the breast
and  right  axillary  tumors  to  be  negative  for
estrogen receptor, progesterone receptor, Her-
2/neu,  CK7,  mammoglobin,  BRST-2,  and
MUC2, focally positive for monoclonal CEA and
CDX2, and positive for MUC1. Fluorescent in
situ hybridization  for  Her-2/neu  was  non-
amplified (Figure 3A, B, and C). A repeat com-
puted  tomography  scan  showed  new  pul-
monary nodules. Thus, systemic chemotherapy
with  capecitabine  and  oxaliplatin  was
resumed. After one cycle, she developed a new
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Figure 1. Computed tomography of the abdomen and pelvis. (A) Demonstrated a thick-
ened bowel with a mass in the rectum (arrow). This study was obtained prior to treat-
ment. A mammogram of the breast (B) demonstrated a lesion shown by the arrow.[page 64] [Rare Tumors 2009; 1:e22]
5 cm soft tissue mass at the level of the skull
base that displaced the cervical right internal
carotid artery interiorly, encased the right ver-
tebral artery, and compressed the right inter-
nal jugular vein. She received palliative radia-
tion therapy to this area. Unfortunately, she
soon developed a new mass adjacent to the pri-
mary  rectal  cancer  that  caused  right  hydro-
dronephrosis for which she had a right percu-
taneous nephrostomy tube placed. Two weeks
after this insult, she developed a small bowel
obstruction.  Following  aggressive  systemic
chemotherapy, she was unable to overcome the
aggressive  metastatic  course  of  the  primary
tumor and expired one year after her initial
diagnosis.
Discussion
The management of disseminated metastat-
ic colon cancer remains a clinical challenge
and surgical intervention has a limited role,
typically performed exclusively for palliation.
Metastatic  spread  from  rectal  cancer  occurs
both by lymphatic and hematogenous routes.
Owing to the venous drainage into the portal
system from the superior hemorrhoidal vein,
the liver is the most common site of distant
metastasis  from  rectal  cancer.
12 Systemic
drainage into the inferior vena cava from the
inferior  hemorroidal  plexus  may  lead  to
metastatic involvement to the lung and bone.
Unusual metastatic lesions from the rectum
to the pancreas (~ 7%)
7,8 and adrenal glands
have  been  reported  (2-17%).
9 Even  more
unusual sites of metastasis originating from
the rectum have been documented to the skin
(<4%)
10 and  the  breast  (Figure  4).
11
Involvement of the skin or breast from rectal
cancer signifies disseminated metastatic dis-
ease and the prognosis for these patients is
exceedingly poor with less than a 20% 1-year
survival.  The  breast  is  an  unusual  site  for
metastatic  deposits.  The  most  common
metastatic deposit of the breast is the result of
a  contralateral  primary  breast  carcinoma.
13
Fine  needle  aspiration  will  identify  extra-
mammary malignancy metastatic to the breast
with a range of 0.5-5%.
14 The three most com-
mon extra-mammary malignancies are bron-
chogenic  carcinoma,  melanoma,  and  lym-
phoma.
13-15 A  wide  array  of  rare  metastatic
deposits might also occur with much less fre-
quency and these include: papillary cancer of
the ovary, squamous carcinoma (SCC) of the
nasal  cavity,  SCC  of  the  cervix,  endometrial
adenocarcinoma,  gastric  cancer,  and  bladder
(Figure  5).
13-15 Extra-mammary  metastatic
deposits  originating  from  the  rectum  is  an
exceedingly rare event. Metastases from the
colon  to  the  breast  were  first  reported  by
McIntosh
16 and  from  the  rectum  by  Lal  in
Case Report
Figure 2. Photomicrograph of rectal mass showing a poorly differentiated adenocarcino-
ma with focal better-differentiated component (right). (A) Hematoxylin and eosin stain
(H&E), x200. (B) Cytokeratin 20 (CK20) immunoreactivity in more differentiated com-
ponent only, x200; (C) CDX2 immunoreactivity in more differentiated area, x200. 
Figure 3. Photomicrograph of breast mass showing morphology and immunoprofile sim-
ilar to the poorly differentiated adenocarcinoma in the rectum with associated dirty
necrosis. (A) Hematoxylin and eosin stain, x200. (B) Focal CDX2 immunoreactivity,
x200. (C) Focal villin immunoreactivity, x200. 
Figure 4. Frequency of rectal metastasis to various organs. The most common sites are the
liver and lungs. 
Figure 5. Thirty-two fine needle aspiration specimens with mestatatic deposits to the
breast in 31 women and 1 man (age 61±3 years old) [range 14-91 years]. The most com-
mon origin was cutaneous melanoma.
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1999.
17 Around 15 reports of rectal metastases
to the breast have been documented since ini-
tially described.
11 As in the case in the present
report, most patients succumb to the aggres-
sive course of the disease within a year after
the diagnosis of the primary tumor. The man-
agement  of  disseminated  metastatic  rectal
cancer remains a clinical and multidisciplinary
challenge. In the past, patients would receive
systemic  chemotherapy  until  their  ultimate
demise.  However,  metastatectomies  are
becoming increasingly common. Traditionally,
metastatectomies have been performed for col-
orectal liver and lung metastases as this has
clearly improved the survival of patients whose
primary  disease  has  been  controlled.
12,18
Metastatectomies for adrenal
9 and pancreatic
tumors
7,8 have also been performed with suc-
cessful outcomes. However, metastasis to the
breast from rectal cancer signifies disseminat-
ed metastatic disease or a highly aggressive
tumor such that metastatectomies in this set-
ting have a limited role other than palliation.
The main form of treatment for these patients
is systemic chemotherapy. 
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